Browse the evidence

Plasma levels of short-chain fatty acids (SCFAs), specifically acetate, are associated with lower cardiovascular disease (CVD) metabolic risk scores, whereas stool levels are not.

For cardiovascular health, the amount of short-chain fatty acids (like acetate) in your blood matters more than what's in your stool. Eating fiber-rich foods (fruits, vegetables, nuts) boosts these beneficial blood levels, which are linked to lower CVD risk. Focus on dietary patterns that support this absorption.

Modifying the composition of existing foods (e.g., reducing energy density) is a faster and more feasible way to change population dietary intake than attempting to change eating behaviors or beliefs directly.

If you want to improve your diet, modify the foods you already eat (e.g., lower fat/sugar versions) rather than trying to learn entirely new recipes or habits. This leverages existing habits and requires less cognitive effort.

Human food preferences and likes are largely learned through exposure and association rather than being innate or purely genetic.

You can change your food preferences. Repeated exposure to new foods, especially in positive contexts, can lead to liking them. Genetics play a minor role.

Nutritional labeling and information can significantly alter the perceived sensory quality and acceptance of foods by setting expectations that consumers try to fulfill.

Be aware that labels like 'low fat' or 'healthy' can change how you perceive the taste of food. This can help or hinder your choices depending on your expectations.

Lorcaserin, a selective 5-HT2C receptor agonist, produces significant, dose-dependent weight loss in obese adults without the need for concurrent diet or exercise modifications.

Lorcaserin is a prescription medication that activates specific brain receptors to reduce appetite. In this 12-week study, obese adults lost an average of 3.6 kg on the highest dose without changing their diet or exercise habits. It is not a standalone solution but a tool to help regulate hunger signals.

High intake of yogurt (specifically fermented milk containing live lactic acid bacteria) is associated with a significantly decreased risk of colorectal cancer (CRC), with a stronger protective effect observed in men compared to women.

Incorporate high-quality yogurt into your daily diet, specifically looking for products with live active cultures (Lactobacillus bulgaricus and Streptococcus thermophilus). The study suggests that consuming roughly 85-100 grams per day (a standard serving) is associated with a lower risk of colorectal cancer. This benefit appears to hold for both full-fat and low-fat varieties, though the effect was statistically stronger in men. You do not need to avoid yogurt due to fat content; the fermentation process and live bacteria are the key factors.

Maintaining an omega-6 to omega-3 fatty acid ratio between 1:1 and 2:1 reduces the risk of chronic diseases including coronary heart disease, cancer, and diabetes by shifting eicosanoid production from pro-inflammatory to anti-inflammatory pathways.

To support long-term health, aim to balance your intake of omega-6 and omega-3 fatty acids. Currently, many Western diets have a ratio of 15:1 or higher. You can improve this by increasing sources of omega-3s (like fatty fish, walnuts, flaxseeds) and moderating high-omega-6 seed oils (like corn, soybean, sunflower oil). A target ratio of 1:1 to 2:1 is associated with lower risks of heart disease and inflammation.

Genetic variants in FADS1 and FADS2 influence the endogenous conversion of omega-6 and omega-3 fatty acids, meaning individuals with certain genotypes may require different dietary intakes to achieve optimal blood levels of long-chain PUFAs.

Your genes affect how well your body converts plant-based omega-3s (ALA) into active forms (EPA/DHA). If you have certain genetic variants, you might need to rely more on direct dietary sources of EPA and DHA (like fish) rather than just flax or chia seeds to get the same benefits.

Current smoking status is a significant independent predictor of attrition (dropping out) from weight loss interventions.

If you smoke, be aware that you are statistically more likely to drop out of a weight loss program. Programs should pay specific attention to smokers to help them stay engaged and adhere to the diet.

Oxyntomodulin (OXM) induces superior body weight loss compared to selective GLP-1 receptor agonists by simultaneously activating both GLP-1 and glucagon receptors, thereby suppressing food intake and increasing energy expenditure.

Oxyntomodulin (OXM) is a gut-derived hormone that activates both GLP-1 and glucagon receptors. Clinical studies show that administering OXM subcutaneously three times daily before meals leads to modest but significant weight loss (approx. 2.3 kg over 4 weeks) in overweight individuals. It also improves glucose tolerance in Type 2 Diabetes patients. The dual receptor activation is key: GLP-1 reduces appetite and slows gastric emptying, while glucagon receptor activation may increase energy expenditure. However, the short half-life requires frequent dosing, and potential side effects like nausea must be managed.

Nonalcoholic fatty liver disease (NAFLD) is strongly associated with metabolic syndrome, with prevalence rates of obesity (51%), type 2 diabetes (23%), and dyslipidemia (69%) significantly higher in NAFLD patients compared to the general population.

If you have fatty liver, check your metabolic health. High rates of obesity, diabetes, and high cholesterol are common companions. Managing these metabolic factors is crucial for liver health.

Physical activity interventions significantly decrease circulating total and free estradiol levels in healthy women, with effects being more pronounced in non-obese individuals and those engaging in high-intensity or resistance exercise.

Engaging in regular physical activity, particularly high-intensity or resistance training, can help lower circulating estradiol levels in women. This benefit occurs independently of weight loss, meaning you can gain hormonal advantages even if your weight stays the same. Aim for varied exercise types, including resistance training, for potentially stronger effects.

Bariatric surgery (Roux-en-Y gastric bypass and sleeve gastrectomy) significantly increases HDL-C levels and improves HDL functionality (cholesterol efflux capacity and apoA-I exchange rate) in obese patients, particularly with sustained effects observed at 12 months post-surgery.

If you have severe obesity and are considering bariatric surgery, know that it is the most effective way to significantly boost your HDL cholesterol levels and improve how well your HDL functions (specifically its ability to remove cholesterol). Studies show that Roux-en-Y gastric bypass and sleeve gastrectomy can increase HDL-C by 30-32% over five years, far outperforming medical therapy alone. However, full functional benefits, such as improved cholesterol efflux, may take up to 12 months to manifest, so patience and adherence to post-surgical care are crucial.

Integrating accelerometer, autonomic nervous system (ANS) signals (heart rate/HRV), and circadian modeling into wearable algorithms significantly improves sleep stage classification accuracy compared to accelerometer-only models.

To get the most accurate sleep data from a wearable ring, ensure it is worn correctly on the finger. The device uses movement, heart rate variability, and body temperature to distinguish between sleep stages. This multi-sensor approach is significantly more accurate than using movement alone, providing reliable data on light, deep, and REM sleep that can be used to guide sleep hygiene and recovery strategies.

Poor sleep quality (PSQI > 5) is significantly associated with increased sick leave, poor physical and psychological health, and work-related problems in white-collar employees, with perceived stress being the strongest correlate.

If you are a white-collar worker experiencing poor sleep, recognize that it is likely contributing to your stress, health issues, and work problems. Prioritize stress management and improving your sleep environment, as these are key factors linked to better sleep quality and overall well-being.

Ephedrine ingestion (1 mg/kg) significantly increases early-phase power output (first 10 seconds) during high-intensity anaerobic exercise (Wingate test) by stimulating the central nervous system rather than skeletal muscle metabolism.

If you take 1 mg of ephedrine per kg of body weight 90 minutes before a short, maximal effort (like a 30-second sprint), you may generate slightly more power in the first 10 seconds. This benefit comes from nervous system stimulation, not muscle fuel. However, the effect vanishes after 15 seconds, and the safety risks (cardiovascular and cognitive) likely outweigh this marginal, short-lived gain for most non-elite users.

Caffeine ingestion (5 mg/kg) significantly increases time to exhaustion and oxygen deficit during supramaximal anaerobic exercise (MAOD test) by enhancing skeletal muscle metabolism and epinephrine release, rather than just CNS arousal.

Take 5 mg of caffeine per kg of body weight 90 minutes before a high-intensity, short-duration effort (like a hard cycling sprint to exhaustion). You can expect to last about 8% longer. This works by boosting adrenaline, which helps your muscles produce energy anaerobically. This benefit applies even if you drink coffee regularly.

Adaptogens (specifically Rhodiola rosea SHR-5, Schisandra chinensis, and Eleutherococcus senticosus) improve mental performance, attention, and endurance in states of fatigue by upregulating the stress-sensor protein Hsp70, which inhibits nitric oxide synthase II and prevents stress-induced ATP depletion.

If you are experiencing mental fatigue or burnout, specific adaptogenic extracts like Rhodiola rosea (SHR-5) taken at 576mg daily for 4 weeks may help improve your attention and reduce fatigue symptoms. Unlike caffeine, these are intended to help your body handle stress more efficiently rather than forcing energy, potentially avoiding the 'crash' associated with stimulants.

Adults in South Asia exhibit a high prevalence (pooled 68%) of vitamin D deficiency, defined as serum levels < 20 ng/mL, with significant heterogeneity across countries and higher rates in females compared to males.

If you are an adult living in South Asia, there is a high likelihood (approx. 68%) that your vitamin D levels are below the recommended threshold of 20 ng/mL. This risk is higher for women due to cultural clothing and lifestyle factors. You should consider getting your serum vitamin D tested and discuss supplementation with a healthcare provider, as dietary sources alone are often insufficient to correct this widespread deficiency.

Binge eating and atypical depression are positively associated with being overweight (BMI > 25) and increased weight gain (BMI slope) in young adults, independent of physical activity and substance use.

If you struggle with binge eating or atypical depression (characterized by oversleeping and overeating), you are at a significantly higher risk of becoming overweight and gaining weight over time compared to those with major depression or generalized anxiety. Addressing the underlying psychiatric condition through therapy or medication may be as important for weight management as diet and exercise.

Sociopathy (defined by antisocial/aggressive behavior in childhood/adolescence) is strongly associated with being overweight, but is NOT associated with the rate of weight gain (BMI slope).

A history of antisocial or aggressive behavior in youth is a strong predictor of being overweight in adulthood, even if it doesn't predict how fast you gain weight. This suggests that early interventions targeting behavioral regulation may have long-term benefits for weight maintenance.

Peripheral administration of PYY 3-36 significantly inhibits food intake in humans by acting on hypothalamic Y2 receptors to suppress orexigenic NPY neurons.

Your gut naturally releases a hormone called PYY 3-36 after eating to tell your brain you are full. Research shows that maintaining or enhancing this signal can significantly reduce how much you eat. While current treatments focus on other pathways, understanding this natural mechanism highlights the importance of foods that stimulate gut hormone release for satiety.

Aerobic exercise (walking/jogging) is associated with lower fat mass in aging men, but does not prevent the age-related loss of fat-free mass.

If you rely on walking or jogging for your fitness, be aware that it will not stop you from losing muscle as you age. To maintain muscle mass, you must incorporate resistance training. Aerobic exercise is beneficial for reducing fat, but it is not a substitute for strength training in preserving fat-free mass.

Older adults experience more severe exercise-induced muscle damage and require longer recovery times than younger adults, increasing their risk of injury and age-related muscle atrophy (sarcopenia).

As you age, your muscles take longer to recover from strenuous exercise, especially eccentric movements. To stay active and healthy, focus on allowing adequate recovery time between intense workouts. Listen to your body's signals of soreness and adjust your training intensity accordingly. This approach helps prevent injury and reduces the risk of age-related muscle loss.